Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients.
about
Neuroinflammation and psychiatric illnessNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceSelective Killing Effects of Cold Atmospheric Pressure Plasma with NO Induced Dysfunction of Epidermal Growth Factor Receptor in Oral Squamous Cell CarcinomaDelineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systemsSelective serotonin reuptake inhibitors and endothelial function in women.Severe depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome.Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review.Nitric Oxide Synthase Inhibitors as Antidepressants.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.The changes in, and relationship between, plasma nitric oxide and corticotropin-releasing hormone in patients with major depressive disorder.Interferon- Gamma- Inducible Guanosine Triphosphate Cyclohydrolase 1 (GTP-CH1) Pathway Is Associated with Frailty in Egyptian ElderlyPlasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
P2860
Q21245244-3ADB6ECB-2001-44D4-8713-90D6EE3A7F38Q26999061-535182AE-F8D2-4E4A-86E3-FD3D1063BF2AQ33467304-85F7C840-40E0-4741-9811-21389C9D9F61Q33635613-D6812789-7247-4B5C-A7B9-99D4F1A5FBBDQ33870796-B125547F-91BB-4494-946F-6E90BB0C49DFQ34613688-1457B9EF-F771-4B6A-AC49-2AF1BF49A1A0Q35143411-1D0A5A43-26B0-48E7-907E-241C69CC6887Q35235141-D5321B52-BF50-4D59-AD91-84F9BD166E55Q35806777-A1EBC95C-C9D9-42BE-8EBD-90179293C41AQ36859519-229182C0-F0B2-4122-86B7-93DDED49B1A3Q37709458-C8294F22-266E-4B58-9BAC-B65AA4503768Q39080324-109EF86C-17A7-47D4-A9F0-9FEAA9C0A2ECQ39295637-F0ED03E1-4D40-4987-8BC0-45481FA36C94Q47812798-56206232-0AED-4D87-8917-B616555D4946Q57489053-DD64F613-9F25-4DAE-8246-DC890CF1EE46Q58772220-7AD88D2B-DBD7-463C-A3AE-449F3E970726
P2860
Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Alteration of decreased plasma ...... oxetine in depressed patients.
@en
Alteration of decreased plasma ...... oxetine in depressed patients.
@nl
type
label
Alteration of decreased plasma ...... oxetine in depressed patients.
@en
Alteration of decreased plasma ...... oxetine in depressed patients.
@nl
prefLabel
Alteration of decreased plasma ...... oxetine in depressed patients.
@en
Alteration of decreased plasma ...... oxetine in depressed patients.
@nl
P2093
P2860
P356
P1476
Alteration of decreased plasma ...... oxetine in depressed patients.
@en
P2093
Glen Baker
Jean-Michel Le Mellédo
Marek W Radomski
Nathalie Lara
Paul Jurasz
Stephen C Newman
Stephen L Archer
Wendy Chrapko
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300961
P407
P577
2006-06-01T00:00:00Z
P5875
P6179
1028699320